exam 2 Flashcards
what is hypertension
- common and manageable chronic condition
- major risk factor for other severe medical disorders
- leads to increased risk of premature morbidity and morality
- > 130/>80
risk factors for HTN
- cigarette smoking
- obesity
- physical inactivity
- excessive alcohol use
- diet
- stress
- dyslipidemia
- diabetes
- microalbuminuria or GFR <60mL/min
- age
- family hx of premature CVD in males below 55 and females younger than 65
BP =
CO x PVR
- mechanisms that involve increased CO, increased PVR, or both will overall increase BP
- anything that increases HR or circulating volume will increase BP
- anything that increases PVR, like angiotensin II will increase BP
increased sodium intake causes
increased sodium fluid retention increasing stroke volume and BP
renin-angiotensin-aldosterone system (RAAS) causes
- excess angiotensin II resulting in vasoconstriction and increased BP
- excess angiotensin also resulting in increased aldosterone
aldosterone causes
- sodium and water retention resulting in increased stroke volume and BP
- enhanced K+ secretion causing low K+
- low K+ increases vasoconstriction through closure of K+ channels
sympathetic nervous system causes
- vasoconstriction reuslting in increased peripheral vascular resistance and increased BP
- ## can increase HR
essential hypertension
- family hx
- african americans
- hyperlipidemia
- smoking
- older than 60 or postmenopausal
- excessive sodium and caffeine intake
- overweight/obesity
- physical inactivity
- excessive alcohol intake
- low K+, Ca+, or Mg
- excessive and continuous stress
secondary hypertension
- kidney disease
- primary aldosteronism
- pheocromocytoma
- cushing disease
- coarctation of aorta
- brain tumors
- encephalitis
- pregnancy
- drugs: estrogen, glucocorticoids, mineralocorticoids, sympathomimetics
out of office and office BP elevated =
sustained HTN
out of office high and office BP normal =
masked HTN
out of office BP normal and office BP high =
white coat HTN
out of office BP normal and office BP normal =
normal BP
elevated BP
120-29/<80 mmHg
stage 1 HTN
130-139/80-89 mmHg
stage 2 HTN
140+/90+ mmHg
hypertensive crisis
> 180/>120
hypertensive urgency
DBP >=120mmHg w/ no s/s of organ damage
hypertensive emergency
DBP >120mmHg w/ evidence of organ damage
renal findings if TOD present
- proteinuria
- elevated BUN and creatinine
- decreased eGFR
endocrine findings if TOD present
- elevated Na+
- elevated K+
- elevated TSH
metabolic findings if TOD present
- fasting blood glucose >100mg/dL
- LDL, triglycerides
- low HDL
other tests for TOD
- left ventricular hypertrophy
- low hematocrit
treatment for HTN
- based on severity
- goal: deccrease BP readings and minimize or prevent end-organ damage
- first step: life style changes
- second step: medications
DASH diet
- 6-8 servings of grains/day
- 4-5 servings of fruits/day
- 4-5 servings of veggies/day
- low-fat or nonfat dairy servings 2-3/day
- lean meats, fish, or poultry servings 6 or fewer/day
- nut, seeds, legumes servings 4-5/week
- fats and oils servings 2-3/day
- sweets 5 or fewer/wk
assessment of HTN
- cardiac
- renal
- neuro
- visual acuity
- vascular
nursing interventions and teaching for HTN
- administer meds
- initiate DASH diet
- promote adherance to meds and lifestyle changes
- educate on how to take BP
- s/s of complications
- overall stress management
complications of HTN
- coronary artery disease
- stroke
- hypertensive crisis
- peripheral vascular disease
- end organ damage: HF, KF
- retinal damage
hypertensive crisis info
- include urgency and emergency
- both are severly elevated BP
- emergency = s/s of organ damage
- acute and life threatening emergency: SBP >180, DBP >120
- requires immediate treatment
- monitor neuro and renal status
- strict I&Os
function of vascular system
- supply adequate circulation of blood to body tissues
- ensure adequate capillary exchange between blood plasma, interstitial fluid, and tissue cells
atherosclerosis
- plaque formation, typically from cholesterol, on interior of vessel wall
- arteriosclerosis often used interchangeably BUT not the same (arterio= genetic term)
- describeds thickening/hardening of arterial wall associated w/ aging
- increases stiffness of artery wall and decreases elasticity of vessel
- comprised of 3 possible path process (medial calcific sclerossis or calcium deposits, arteriolar sclerosis or thickening of smaller arterioles, or atherosclerosis or LDL build up on arterial wall
- primary cause of many vascualr disorders
risk factors of atherosclerosis
- starts in childhood and increases w/ age
- elevated LDL or HDL
- elevated triglycerides
- HTN
- diabtetes
- smoking
- family hx
- sedentary lifestyle
- males or postmenopausal women
- black and hispanic people have increased incidence of smoking, diabetes, and HTN
- whites have high abnormal serum lipids
pathophysiology of atherosclerosis
- disease in which LDL builds up on arterial walls
- slow developing complex disorder
- begins from vessel damage causing inflammation leading to accumulation of atherosclerotic plaque, once inflamed fatty streaks appear on lining of artery
- lipids become deposited on arterial wall thickening arterial wall and decreases internal diameter of artery
- causes decreased BF and O2 to affected tissues
- plaques may rupture and cause blood clots to form and block blood flow entirely
clinical manifestations of atherosclerosis
- little to no s/s
- progresses as the vessel narrowing becomes critical; pt typically ends up in ER for MI, unstable angina, sudden cardiac arrest, stroke, or death
- depends on location and degree of severity of atherosclerotic disease
- frequently manifests as chest pain (angina), SOB, fatigue, arrythmias
carotid cartery atherosclerosis can lead to
stroke
cardiac artery atherosclerosis can lead to
MI or cardiac arrest
peripheral artery atherosclerosis can lead to
pain and reduced functionality of extremities
can cause gangrene (death of body tissue r/t lack of blood flow and oxygenation
medical management of atherosclerosis
- identify and control risk factors for development
- med management and decrease lipid levels
- anticoagulants to prevent clot formation
- diabetes management
- encourage modification of dietary habits, smoking, exercise, stress levels/relief techniques
surgical management atherosclerosis
reserved for irreversible manifestations of atherosclerosis
assessment and analysis of atherosclerosis
- manifestations vary based on arteries involved
- complete pt hx and cardiovascular assessment
- assess BP in both arms
- palpate pulses at all major sites in body (note differences at any/all locations
- auscultate for bruits
- lab values, fasting lipid profile, triglyceride levels, homocysteine, glyc
nursing diagnoses/problem list for atherosclerosis
- risk for ineffective tissue perfusion
- pain r/t decreased BF
- activity intolerance/fatigue
nursing interventions for atherosclerosis
- assessments
- administer meds or management of HTN and lipids
- BP management
- lifestyle changes
evaluation of outcomes for atherosclerosis
- well managed through diet, activity, and stress management
- smoking cessation
- evaluate severity and/or resolution of symptoms
- pt’s will be monitored through follow up care with providers as lifelong treatment
epidemiology of PAD
- affects >230 million
- significant morbidity, mortality, and alterations in quality of life
- atherosclerosis is MAIN contributor to PAD
- risk factors of atherosclerosis are also risk factor of PAD
pathophysiology of PAD
- progressive and chronic condition
- blood flow through large peripheral arteries is obstructred causing partial or total occlusion
- caused by combo of atherosclerosis, inflammation, stenosis, embolus, or thrombus
- deprives lower extremities of oxygen and nutrients
- causes ischemia, necrosis, and cell death
clinical manifestations of PAD
- most often seen as atypical lower extremity pain or intermittent claudication (muscle pain occurring during exercise)
- described as ache, cramp, numbness, or sense of fatigue
- most often in calf
- typically relieved by rest
- limited or painful joints, ulcerated or cold extremities, painful stretching
- limits exercise ability and QOL
stage 1 PAD
- no claudication/pain
- bruit may be heard
- pedal pulses are decreased or absent
stage II PAD (claudication)
- muscle pain, burning, and cramping experienced w/ exercise and relieved by rest
- pain is reproducible with same amount of exercise
stage III (rest)
- pain at rest
- often awakens pt at night
- numbness and burning in distal portions of extremity
- relieved by putting extremity in dependent position
stave IV PAD (necrosis/gangrene)
- ulcers and blackened tissue in toes, forefoot, or heel
- gangrenous odor may be present
diagnosis of PAD
- complete vascular assessment (pulses, auscultation of femoral bruits, inspection of legs and feet)
- all physical assessment findings must be confirmed w/ diagnostics
- ankle-brachial index (doppler probe to compare BP at ankle to brachial artery, ankle should be higher)
- plethysomography (evaluates arterial flow to lower extremities done through pulse volume measurements and tracings)
- anatomical imaging reserved for highly syptomatic patients who need to undergo surgery (duplex u/s, CTA, MRA, invasive angiography)
ABI values
> 1.30 - noncompressible arteries
- 1-1.29 = normal
- 0.91-0.99 = borderline
- 0.41-0.9 = mild to moderate
- 0-0.4= severe PAD
goals of PAD treatment
- provide relief of symptoms and improve QOL
- prevent progression of arterial disease
- prevent cardiovascular complications
- provide further education about disease
treatment of PAD
- first line: nonpharmacological interventions
- weight loss, smoking cessation, exercise, adherance to low fat diet
medications for PAD
- target risk factors that may profress the atherosclerotic process
- antihypertensives
- antiplatelets
- statins
nonsurgical interventions for PAD
- positioning and promotion of vasodilation (legs in dependent position)
- exercise
- percutaneous transluminal angioplasty (helps improve arterial BF by inserting cannula into occluded artery placing a stent to open up artery
- laser-assisted angioplasty (cannula inserted into occluded artery and laser probe heat vaporizes blockage in smaller occlusions and vessels)
- rotational atherectomy (hard, calcified lesions to remove plaque by breaking it into small peices)
surgical interventions for PAD
- when clients have severe pain at rest or claudication interfering with ability to perform ADLs
- revascularization through surgical bypass graft placement to byspass BF and use autogenous grafts
complications of PAD
- critcal limb ischemia
- acute limb ischemia
critical limb ischemia
- sustained and severe decrease in arterial blood flow
- leads to chronic ischemia, pain at rest, ulceration, gangrene
- present after long term PAD
- prognosis generally poor
- further risk of infection, cellulitis, and tissue breakdown
- requires revascularization surgery with about 40% needed limb amputation within 6 months
acute limb ischemia
- sudden decrease in blood flow to extermity
- acutely thretens tissue viability
- may be first presenting symptoms of PAD
- may be caused by acute event
- most common cause = embolus
- more common in lower extremities
- manigested by severe pain, pallor, pulselessness, paresthesia, paralysis, and poikilothermia (six P’s)
- requires immediate intervention to preserve tissue and save limb
- anticoag and potential revascularization treatment
assessment and analysis of PAD
- clinical manifestations vary with affected tissue
- bilateral BP
- palpate all pulses in both legs
- visual assessment of feet and legs
- temperature of bilateral lower extremities
- assess pain and s/s of infection in lower extremities
nursing diagnoses/problem list in PAD
- ineffective peripheral tissue perfusion
- risk for impaired skin integrity
- chronic pain
- bleeding risk
- risk for unstable blood pressure
- impaired mobility
- risk for infection
nursing interventions for PAD
- assess client
- admin meds
- properly position patient to help w/ tissue perfusion
- independent positioning to help w/ BF
- inspect feet daily and report skin changes
- report chest discomfort or neuro changes
- lifestyle changes; DASH diet, limit alc, smoking cessation, moderate exercise
evaluating outcomes of PAD
- symptoms relief
- pain free and able to participate in normal activites
- decreased progression of illness
- improved QOL
- adherance to lifestyle changes and med regimen
carotid artery disease epidemiology
- common atherosclerotic vascular disease
- typically begins developing in 40s
- prevalence increases w/ age
- higher incidence in males and white and native american populations
risk factors for carotid artery disease
- smoking
- HTN
- diabetes
- dyslipidemia
- sedentary lifestyle
- obesity
- poor stress management
- age <75
- male gender
- hx of CAD
pathophysiology of carotid artery disease
- vessel wall thickening plaque formation and progressive narrowing of carotid arteries
- plaque disruption and thrombus formation is possible
- stenosis is most significant at carotid bifurcation
- severity based on vessel lumen diameter
clinical manifestations of carotid artery disease
- asymptomatic until vessel lumen is obstructed to point of causing cerebral perfusion impairment
- bruit will be present past obstruction at bifurcations
-s/s of transiet ischemic attack (sudden weakness, dizziness or loss of coordination, difficulty talking, facial drop on one side, sudden vision problems, sudden and severe headache
diagnosis of carotid artery disease
- physical assessment, noninvasive procedures, and occasionally invasive procedures
- conventional carotid angiography is invasive procedure that is the gold standard for diagnosis of severity of external carotid artery stenosis
- done through catheterization of femoral artery and use of contrast dye to visualize the blockages
noninvasive tests for carotid artery disease
- carotid duplex u/s
- MRA
- MRI
- CTA
treatment of carotid artery disease
- depends on severity of occlusion and whether the patient is symptomatic or asymptomatic
- asymptomatic patients w/o hx of stroke or TIA: optimal medical therapy which is a combo of lifestyle change and medications (antiplatelets, antihypertesnives, statins, etc.)
- surgical intervention is controversial due to complications
- symptomatic patients who present w/ TIA or stroke include OMT and surgical management
surgical management of carotid artery disease
- procedures for revascularization
- carotid endarterectomy (CEA): removal of plaque to improve BF and prevent stroke w/ med management of antiplatets, hypertesnives, and statins
- carotid artery stenting (CAS): in combination w/ carotid angioplasty where stent is placed to open artery requiring lifelong aspiring
CEA postop priorities
- tight BP monitoring
- neuro assessments
- bleeding prevention
CAS post op priorites
- frequent VS monitoring
- neuro assessments
- access site monitoring
assessment and analysis of carotid artery disease
- typically asymptomatic until lumen is obstructing cerebral BF
- symptoms of stroke may appear
- auscultate carotid arteries for bruits
- vital monitoring (!BP!)
- neuro assessments
- stroke hx or s/s of stroke
nursing diagnosis for carotid artery disease
- risk of poor tissue perfusion
- risk for injury
- anxiety
- risk for bleeding
- risk for fluctuations in BP and HR
nursing interventions for carotid artery disease
- post op monitoring of RR, SpO2, presence of stridor or tracheal deviation, vitals, cranial nerves and renal function
- admin meds as ordered
- manage diabetes and maintain glucose levels
- postop: keep BP within ordered parameters, maintain neutral head alignment, encourage fluids
- educate on s/s of stroke
- lifestyle changes, DASH, exercise, smoking cessation, limitation of alcohol
evaluating care outcomes of carotid artery disease
- educated on risk factor modifications
- compliance of medication regimen
- adherence to lifestyle changes
- goal of no clinical manifestations of stroke
- no post-op complications of pain, swelling, or bleeding
epidemiology of aneursyms
- common in men
- common in white people
- common in those with atherosclerosis
- thoracic aortic aneurysms (TAAs) more common in men 40-70yo
- non-modifiable risks: family hx, advanced age, male sex, genetic abnormalities, known CAD, Marfan’s syndrome
- modifiable risks: smoking, high cholesterol, HTN
causes of aneurysms
- atherosclerosis
- chronic inflammation (aortitis)
- blunt trauma
pathophysiology of aneurysms
- permanent localized dilation of an artery that forms when middle layer of artery is weakned
- causes stretching in artery walls increasing tension
- can occur in ascending, descending (thoracic), or abdominal aorta
- all 3 layers are weak
medical management of aneruysms
- imaging to detect aortic dilation
- CT scan w/ IV contrast is gold standard
- abdominal u/s or transthroacic echocardiography
- cardiac MRI
- ECG to rule out MI
- meds: focus on reducing growth and preventing complications, aggresive HTN management, antibiotic to prevent infections, statins to reduce atherosclerosis and growth
surgical management of aortic aneurysms
- determined by size, location, and presence of symptoms
- surgery is only effective in preventing AAA rupture and anuerysm related death
- most commonly a resection and repair (aneurysmectomy)
- risk of bleeding, infection, MI, renal failure, and graft occlusion
- endovascular aneurysm repair is less invasive w/ less risk
aneurysmectomy
aneurysm is excised and graft is applied
endovascular aortic repair (EVAR)
placement and attachement of sutureless aortic graft prosthesis across aneurysm
aortic dissection
- caused by sudden tear in aortic intima creating a false lumen in artea
- life threatening emergency due to loss of circulation to major arteries
- s/s: sudden, severe, persistent pain in anterior chest or back, pain extends to shoulders, epigastric area, or abdomen, desrcibed as “ripping” or tearing, diaphoresis, n/v, faintness, tachycardia, BP different in LUE than RUE
aneurysm rupture
- life threatening
- leads to sudden and extreme blood loss
- s/s similar to dissection w/ LOC and hypovolemic shock
- death rate about 80%
assessment and analysis of anerysms
- assessments
- vitals specifically for hypotension and tachycardia for concern of rupture
- neuro assessment
- pain presence and severity
- peripheral pulses, skin color, temp
- peripheral sensation and motor response
- gentle abdominal auscultation and palpation
nursing diagnosis for aneurysms
- risk for ineffective peripheral tissue perfusion
- acute pain
- fear
- risk for bleeding, decrease CO, and hypovolemic shock
- risk for fluctuations in BP
nursing interventions for aneurysms
- assessments
- admin meds as ordered
- admin stool softners
- reduce stress
- educate on s/s of aneurysm complications
- marfan’s syndrome: encoruage to do regular screening and call HCP w/ new onset of s/s
- strict treatment regimen: med compliance, weight reduction, smoking cessation, regular exercise, avoid crossing or eelvating legs, reduce stress
evaluating care outcomes of anerysms
- compliance w/ perscribed therapy
- BP and HR WNL
- strong peripheral pulses
- normal skin color and texture
- no complaints of abdmoinal, back, or chest pain
- no complaints of wheezing or SOB
- no complaints of dysphagia or hoarsness
- normal neuro assessment
epidemiology of DVT
- 1/1000 per year
- 0.5-7/1000 pregnancies
- can detach from site of formation and become mobile in blood stream leading to PE or MI
- risk increases w/ prolonged bedrest, venous stasis, surgery, increased age, active cancer w/ or w/o chemo, varicose vevins, prior VTE, pregnancy, postpartum, oral contraceptive use, hormone therapy, surgery, trauma, covid-19
pathophysiology of DVT
- virchow’s triad= factors implicated in formation of VTE
- decreased BF rate or statsis of BF
- damage to vessel wall or endothelial cell injury
- increased tendency for blood to clot (hypercoaguability)
- more common in lower extremities and creates environment for clotting
clinical manifestations of DVT
- clot can cause complete or partial blockage of circulation in vein
- pain, swelling, tenderness, discoloration or redness, warmth
- Homan’s sign= calf pain elicited by dorsiflexion of foot
- ^ can indicate presence of DVT but is not diagnostic
diagnosis of DVT
- pretest probability
- d-dimer (if high, clot is present)
- compression u/s (CUD) to visualize thrombi and ID if unstable or floating
prevention of DVT
- early ambualtion
- VTE prophylaxis (LMWH, compression stokcings
meds for DVT
- anticoag w/ LMWH or heparin
- long term anticoags w/ warfarin or eliquis or apixiban
- thrombolytic agent only used as VERY LAST resort
surgical management of DVT
- rarely used unless massive occlusion not responding to treatment
- must be recent
- thrombectomy
- less invasive= ballon angioplasty
coplications of DVT
- PE: SOB, decreased SpO2, tachycardia, hypotension, sweating, sharp chest pain, hemoptysis, increased PVR, incerased workload on heart, deceased O2 on lung
- post-thrombotic syndrome: chronic disorder ranging from limb swelling and discomfort to sever leg pain, intractable edema, irreversible skin changes and leg ulcers
assessments for DVT
- vitals w/ o2
- extremity assessment for pain, tenderness, warmth, redness, or swelling
- compare R and L calf, thigh, or arm
- gentle palpation to insepction for induration
- D-dimer test
- lab values: INR, PT/aPTT, H/H
- assess for s/s of bleeding
nursing diagnosis for DVT
- ineffective peripheral tissue perfusion
- acute pain
- risk for impaired physical mobility
- risk for bleeding
- impaired gas exchange
nursing interventions for DVT
- assessment
- early ambulation
- leg elevation
- compression stockings
- avoid use of SCDs
- encourage adeuqate fluid intake
- admin meds
- educate of prevention: ambulation, fluids, avoid constricting clothing, avoid long periods of sitting/car rides/ planes
- educate on s/s of bleeding
- educate on lab compliance
- safety precautions when taking anticoags
evaluating care outcomes for DVT
- compliance w/ prescribed anticoagulants
- stable vs and O2 sat
- decreased extremity pain, tenderness, or swelling
- prevention activities and maintenance of active and healthy lifestyle
chronic venous insuffiency risk factors
- obesity
- smoking
- sedentary lifestyle
- increased age
- prolonged standing
- previous LE trauma or thrombosis
- HTN
pathohypsiology of CVI
- superficial and deep veins of peripheral venous system consist of one-way bicuspid valves
- most likely caused by congenital factors, hormones, prolonged standing, thrombosis, or non-thrombotic events
- DVT is usually results in deep vein incompetence
- valves become damaged and venous pressure increases, blood reutnr from lower extremities is obstructured leading to arterial perfusion impairment, lower extremity edema, skin ulcers
clinical manifestations of CVI
- lower extermity pain and edema
- dilated veins
- skin changes: capillary walls thicken causing breakdown of RBCs, brown skin, tissues and cells will necrose, fibrous tissue begins to develop in subq fat
- ulcer formation
diagnosis of CVI
- rule out other causes
- ID clinical changes, dialted vessels, skin changes, and ulcers-
treatment of CVI
- compression and avoiding prolonged standing
- compression stockings
- basic skin care
- wound care
- exercise w/ walking and ankle flexion increasing venous return
leg elevation - adequate nutrition
meds for CVI
- cellulitis development so may need antibiotics
- wound care
- aspirin and steroids
surgical management of CVI
- varicose vein treatment
- complicated, infected wounds may need debridement to remove necrotic tissues
complications of CVI
- leg discoloration
- dilated veins
- edema
- leg pain
- ulcers
- cellulitis
- sepsis
- limb amputation
- DVT or PE
assessment of CVI
- clinical manifestations
- vs and O2
- monitor extermities for edema, dilated vessels, skin discoloration, pain, warmth, redness, or ulcer formation
nursing diagnosis for CVI
- risk for infection
- risk for ulcer formation
- impaired mobility
- pain
- edema of extermities
nursing interventions for CVI
- provide skin care and apply dressings
- compression therapy
- elevation of extremities
- encourage ambulation
- admin meds as ordered
- education on compression therapy, skin care, exercise, elevation, and nutrition
- educate on importance of avoiding prolonged standing
evaluating care outcomes for CVI
- demonstrating adgerence to treatment regimen
- demonstrate decreased leg swelling, vein dilation, and ulcer formation
- increased exercise tolerance and elevation of legs when resting
- compliant with compression therapy, skin care, and nutrition
epidemiology of HF
- prevalent in 6.5 million people over age 20
- high mortality rate
- more common in those: over 65, african americans, previous heart attacks, obesity
risk factors for HF
- CAD
- HTN
- DM
- metabolic syndrome
- obesity
- smoking
- high Na+
- sleep apnea
common conditions causing HF
- valvular dysfunction
- cardiomyopathies
- infections and inflammatory heart disorders
- dysrythmias
- anemia
- thyroid disease
- cardiotoxic substance exposure (alcohol, chemo, drugs)
less common conditions causing HF
- respiratory conditions
- pulmonary artery HTN
- COPD
- interstitial lung disease
- obstructive sleep apnea
pathophysiology of HF
- progressive disease characterized by myocardial cell dysfunction and decreased CO
- frank-starling law: increased blood in ventricles cause increased contracility of ventricle
- constant demands of myocardial muscles
- weakned heart muscles and inability to contract efficiently
- compensatory mechanisms kick in
compensatory mechanisms
- SNS
- ventricular remodeling
- neurohormonal responses (RAAS, BNP)
- all short term compensation
ventricular remodeling
- causes fibrosis, cardiomyocyte loss, cardiomyocyte hypertrophy, and electrophysical changes
- ^ leads to impaired contractility, LV dilation, and wall thinning leading to HF
HF w/ reduced EF
- weakened heart contraction
- EF 40% or less
HF w/ preserved EF
- EF maintained above 50%
- ventricles have impaired ability to fill
normal EF
55-70%
AHA HF
a- no risk factors but s/s
b- no s/s but elevated heart pressures or BNP
c- current or past s/s of HF
d- marked signs that interfere w/ daily life
NYHA HF
I: no s/s w/ physical activity
II: mild s/s w/ ordinary activies
III: marked limitation w/ activity but comfortable at rest
IV: severe limitation
clinical manifestations of HF
- acute: sudden onset and immediate interventions
- chronic: basline set of symptoms, limitations are relatively stable w/ treatment and self-management
- fatigue
- weight gain
- tachycardia
- hypotension or hypertesnion
- heart murmurs related to valve dysfunction
- S3 may be present
- S4 common in chronic heart failure
s/s of right sided HF
- fatigue
- increased peripheral venous pressure
- enlarged liver or spleen
- distended jugular veins
- anorexia or GI distress
- swelling in hands and fingers
- dependent edema
s/s of left sided HF
- dyspnea
- orthopnea
- bendopnea
- edema
- fatigue
- crackles on auscultation
- poor skin color and delayed cap refill
- weak pulses
- cool skin temp on extremities
heart failure progression
- L HF can lead to R HF
- heart may be initally affected in its entireity
- s/s become less clear
- can have exacerbations: hypotension, cool extremities, decreased/no output, poor decreasing mentation
- +S3 and 4
diagnosis of HF
- imaging to rule out other problems and cause
- imaging: xray, echo, CT, MRI, ECG, nuclear imaging
- labs: cardiac biomarkers, serum electrolytes, CBC, urinalysis, glucose levels, fasting lipids, LFTs, renal function tests
- biomarkers: BNP and n-terminal pro B-type natiuretic peptides, troponins
- nuclear imaging
- stress test
- coronary angiography
- exercise testing
medical management of HF
- medications most often used for HF w/ reduced EF
- for HF w/o reduced EF treatment of underlying cause, BP control, diuretic and s/s management
- goal: reduce risk factors, manipulation of critical component of CO- preload, afterload, and contractility
- successful management: slows disease progression, prevents complications, reduces morbidity and mortality, improves QOL
risk factor management for HF
- BP and glucose control
- weight loss
- optimizing serum lipids
- smoking cessation
meds that impact preload
diuretics
meds that reduce afterload
ACE inhibitors
ARBs
ARNIs
meds to affect contractility
postive inotropic agents (digoxin)
management of HF exacerbation
- IV meds for quick and effective management
- goal to decrease preload and afterload and increase contractility
- vasodilators
- IV inotropic and inodilators
- requires VS monitoring: frequent BP/HR, cardiac monitoring and rhythm assessment
furosemide and morphine
can cause hypotension
BP monitoring frequently
LOC monitoring
K+ monitoring
UO monitoring
fall precautions
CNS depression
device and surgical interventions
- implantation of ICD for dysrhythmia control and ventricular resynchronization
- intra-aortic balloon pump
- ventricular assist device
- valve replacement
- heart transplant